β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs

(2013) Q. Quentin Li et al.   MEDICAL ONCOLOGY

Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells

(2012) Qingdi Quentin Li et al.   MEDICAL ONCOLOGY

Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1 and inhibition of platinum–DNA adduct repair

(2012) K Kudo et al.   ONCOGENE

DNA Damage and Repair in Translational Oncology: An Overview

(2010) E. Reed   CLINICAL CANCER RESEARCH

Antineoplastic effect ofβ-elemene on prostate cancer cells and other types of solid tumour cells

(2010) Qingdi Quentin Li et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

β-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis

(2009) Li   ONCOLOGY REPORTS